Maximus, Inc. (NYSE:MMS – Get Free Report) saw a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 1,650,000 shares, a decline of 27.0% from the January 15th total of 2,260,000 shares. Currently, 3.0% of the company’s shares are short sold. Based on an average daily volume of 921,500 shares, the short-interest ratio is presently 1.8 days.
Analysts Set New Price Targets
A number of equities analysts have recently commented on MMS shares. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Friday.
Check Out Our Latest Research Report on Maximus
Insider Transactions at Maximus
Hedge Funds Weigh In On Maximus
Institutional investors have recently made changes to their positions in the stock. V Square Quantitative Management LLC acquired a new position in shares of Maximus during the third quarter valued at about $25,000. UMB Bank n.a. raised its holdings in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 158 shares during the period. Eastern Bank acquired a new position in shares of Maximus during the fourth quarter valued at about $29,000. R Squared Ltd acquired a new position in shares of Maximus during the fourth quarter valued at about $54,000. Finally, IFP Advisors Inc raised its holdings in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.
Maximus Trading Up 1.0 %
MMS stock traded up $0.66 during midday trading on Friday, hitting $67.76. The stock had a trading volume of 60,055 shares, compared to its average volume of 703,359. The firm has a market cap of $3.87 billion, a P/E ratio of 14.53 and a beta of 0.72. The company has a current ratio of 1.72, a quick ratio of 1.49 and a debt-to-equity ratio of 0.82. Maximus has a 1-year low of $66.52 and a 1-year high of $93.97. The business has a fifty day moving average price of $74.22 and a two-hundred day moving average price of $82.73.
Maximus (NYSE:MMS – Get Free Report) last released its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, sell-side analysts predict that Maximus will post 6.05 earnings per share for the current fiscal year.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.77%. Maximus’s dividend payout ratio is currently 25.81%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
- Five stocks we like better than Maximus
- What Are Some of the Best Large-Cap Stocks to Buy?
- Up 50% in January, Twilio’s Pullback is the Time to Buy
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
- Transportation Stocks Investing
- Cisco Roars Back: Is the Tech Giant Reborn?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.